An important target in the understanding of the pathogenesis of acute myeloid leukemias (AML) relies on deciphering the molecular features of normal and leukemic hemopoietic progenitors. In particular, the analysis of the mechanisms involved in the regulation of cell proliferation is decisive for the establishment of new targeted therapies. To gain further insight into this topic we report herein a novel approach by analyzing the role of HERG K + channels in the regulation of hemopoietic cell proliferation. These channels, encoded by the human ether-agò -gò -related gene (herg), belong to a family of K + channels, whose role in oncogenesis has been recently demonstrated.
Introduction
The demonstration that acute myeloid leukemia (AML) is a disease of hemopoietic stem cells has raised fundamental questions concerning the true target of leukemic transformation in this disease. 1 In this light, many studies have been focused on the identification and characterization of leukemic progenitor cell populations in patients with AML. [2] [3] [4] While the phenotype of leukemic stem cells has been defined, [2] [3] [4] [5] [6] [7] it is emerging that primitive AML cells aberrantly express several set of genes, particularly those involved in the regulation of cell cycle progression and apoptosis. 8, 9 Hence, the comparison between the pattern of genes expressed in normal vs leukemic progenitors is now regarded as a fundamental topic in the understanding of the biological features of malignant transformation leading to AML development.
A novel approach in this field is the study of the expression of ion channel encoding genes during cell cycle progression. In fact, recent studies suggested that ion channels, particularly K + channels, are important regulators of cell proliferation, 10 and it has been hypothesized that the activation of K + channels is required for the progression of cells through the G 1 phase of the cell cycle. [11] [12] [13] [14] [15] Moreover, the proliferation of nor- mal and tumor cell lines [16] [17] [18] [19] [20] [21] [22] is often reduced and sometimes blocked by K + channel inhibitors. More recently, K + channel expression has been linked to the activity of well-known oncogenes 23 and a direct oncogenic potential has been attributed to K + channel encoding genes. 24 A possible link between K + channel activity and cell proliferation could be the clamping of the resting membrane potential (V REST ) value, usually afforded by these types of channels. Oscillations of V REST in phase with the cell cycle transitions have been observed in various cell types, and particularly K + -dependent hyperpolarizations at the G 1 /S boundary. 10 On the other hand, while terminally differentiated, G 0 cells are usually hyperpolarized (with V REST between −50 and −70 mV), cycling, and especially tumor cells tend to be depolarized. 27 A contribution to explain this complex pattern came from our demonstration that, in a set of tumor cells, V REST is often clamped to almost depolarized values by HERG K + currents (I HERG ). The human eag-related gene (herg) belongs to an evolutionary conserved multigenic family of voltage-activated K + channels, the eag (ether a-gò -gò ) family, 26 and encodes for a channel contributing to the cardiac repolarizing current I Kr . 27 I HERG besides being a very tiny current, has profound physiological importance: in fact, in the cardiac model I Kr regulates the repolarization phase of the action potential and its alterations lead to dramatic cardiac arrhythmias. Moreover, since the steady-state conductance of HERG channels is maximal around −30/−40 mV, I HERG appears to be particularly suitable to the clamping of V REST around these values in non-excitable cells, such as neoplastic or immature cells. Indeed, we showed that both herg and I HERG are preferentially expressed in tumor cell lines of different histogenesis, 28, 29 in primary human endometrial cancers, 30 as well as in neuroblasts and myoblasts only at very early stages of embryo development, 31, 32 and determine the V REST values in these cells. 28, 29, 33, 34 Moreover, the human cell line FLG 29.1 derived from a patient with M5a type leukemia 35, 36 expresses herg and a V REST which is governed by a unique K + current, namely I HERG , whose biophysical features keep this potential at strongly depolarized values. 37 In these cells I HERG is modulated by integrin activation, and acquires the ability to regulate gene transcription leading to osteoclastic differentiation; in these conditions cells stop growing while undergoing a significant hyperpolarization of the V REST . 38 We present here a study on the expression and role of herg encoded channels in the hemopoietic system in both normal hemopoietic precursors and leukemic blasts present in AML. herg expression was first tested in resting peripheral mononuclear cells (PBMNC) obtained from normal donors as well as in CD34
+ collected from peripheral blood (PBCD34 + + cells). [39] [40] [41] We report here that both PBMNC and PBCD34 + cells do not express herg, which is however rapidly up-regulated in the latter upon induction of proliferation by cytokines/growth factors. Moreover, this activation turned out to be necessary for CFU-GM proliferation in vitro. We also report that various myeloid leukemia cell lines as well as most human AML express herg and HERG channels in a definite subset of circulating blasts. Evidence is also reported demonstrating that HERG activity can control leukemia cell proliferation as well as the clonogenic potential of leukemic blasts present in the peripheral blood of AML.
On the whole, this study lends support to configuring herg as a proliferation-related gene, which is rapidly activated during cell cycle progression of human hemopoietic progenitors, while being constitutively expressed in immature leukemic cells.
Materials and methods

Isolation of peripheral blood mononuclear cells
Peripheral blood samples from 21 healthy donors were subjected to Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) gradient centrifugation. Mononuclear cells were recovered at the interphase, washed and counted.
Preparation of CD34
+ cells 
Isolation of leukemic blasts
Leukemic blasts were obtained from the peripheral blood of 46 patients (classified according to the French-American-British committee), treated either at the Hematology Unit of Firenze or at the Department of Internal Medicine of Torino, with newly diagnosed AML before chemotherapy. Enriched populations of blast cells (more than 95%) were obtained by FicollHypaque (Pharmacia) density gradient centrifugation. In some cases the cells were cryopreserved and stored in liquid nitrogen until use. The frozen AML cells were thawed, washed with RPMI 1640 medium (Hyclone, Logan, UT, USA), resuspended in IMDM (EuroClone Ltd, UK) medium containing 5% bovine calf serum (BCS) (Hyclone) at the concentration of 2 × 10 6 /ml and incubated overnight at 37°C. After removal of clumped cells by sedimentation, the samples had a viability greater than 90%.
Cytofluorimetric analysis
Samples of 10 6 cells/ml were stained with propidium iodide (PI) as described by Vindelov and Christensen. 42 The samples were analyzed using a FACScan flow cytometer (Becton Dickinson, San José, CA, USA) equipped with a 5 W argonion laser. Histograms of cell number vs linear integrated red fluorescence were recorded for 50 000 nuclei/sample and were analyzed using the MultiCycle DNA content and cell cycle analysis software (Phoenix Flow Systems, San Diego, CA, USA) to evaluate the distribution in the phases of the cell cycle.
Cell culture and analysis of cell proliferation
The following leukemia cell lines were analyzed: FLG 29.1, 28 K562 (a cell line derived from the acute phase of a chronic myeloid leukemia 43 ) and HL60 (a promyelocytic cell line 44 ). Cells were cultured in RPMI with 5% heat-inactivated FCS (Hyclone Characterized, Logan, UT, USA) and maintained at 37°C in a humidified atmosphere in 5% CO 2 
Clonogenic assay
AML blasts were seeded at a density of 1 × 10 6 in a 1 ml of mixture containing IMDM, 20% FCS, 10% agar and recombinant cytokines at the following concentrations: IL-3 10 ng/ml, GM-CSF 20 ng/ml, SCF 50 ng/ml, G-CSF 20 ng/ml. Each sample was then seeded in triplicate wells of a 24-well microplate in the absence or in the presence of the specific HERG current blocker Way 123,398 (200 M, final concentration) and incubated at 37ºC in a humidified atmosphere in 5% CO 2 in air. After 10 days of incubation, all the aggregates containing more than eight cells were enumerated in each well and the results averaged. 10 6 non-adherent mononuclear cells (MNAC) from normal peripheral blood were seeded as decribed above. Colonies and clusters were counted after 14 days of incubation.
CFU-GM assay
RNA extraction and reverse transcription polymerase chain reaction (RT-PCR)
Mononuclear cells were washed twice in ice-cold PBS and collected by centrifugation. Cells were homogenized in a guanidinium thiocyanate solution, and total RNA was extracted according to Cherubini et al. 30 RNA purity and integrity was always checked by running an aliquot on a denaturing 1% agarose gel. 45 cDNA was then synthesized from 1-2 g of RNA using 200 U reverse transcriptase SuperScript II (Invitrogen, Groningen, The Netherlands), plus 200 M each of dNTP and 2.5 M random hexamers, in a 20 l final reaction volume, for 50 min at 42ºC and 15 min at 70ºC. Two l of cDNA were then amplified by polymerase chain reaction in a 50 l reaction containing Herculase enhanced DNA polymerase 2.5 U (Stratagene, La Jolla, CA, USA), 200 M d(NTP)s, 1× Herculase polymerase reaction buffer. The oligonucleotide primers were as reported in Cherubini et al. 30 These primers encompass a nucleotide region from 2171 to 2746 of the human herg cDNA giving rise to a band 575 bp long. Thirty-five cycles of amplification were carried out after 2 min of enzyme activation at 94°C; denaturation was at 94°C for 30 s, annealing at 56°C for 1 min, and extention at 72°C for 1 min. Samples of PCR products were run on a 1.5% agarose gel using a molecular weight marker, the 100 bp DNA ladder (New England Biolabs, USA) and bands were visualized by ethidium bromide staining on a UV transilluminator. Control amplifications were performed adding either no DNA, no RNA and no retrotranscribed RNA in the PCR tube, but non-specific bands were never observed. cDNA samples were checked for integrity by PCR detection of human gapdh using the same conditions described above and using the same primers as reported in Cherubini et al. 30 
Immunocytochemistry
Leukemic cells were cytocentrifuged at 300 r.p.m. for 3 min and fixed in ethanol for 10 min at room temperature, and air dried before further analysis. Endogenous peroxidase activity was blocked by incubating the cells with 0.5% H 2 O 2 in water for 10 min at room temperature. Before proceeding with the BioGenex Super Sensitive Detection System (BioGenex, San Ramon, CA, USA), cells were permeabilized with 0.2% Triton X-100 in Ultra V Block (Lab Vision, Fremont, CA, USA) for 20 min at room temperature. Slides were extensively rinsed with PBS and then incubated with the anti-HERG primary antibody (Alomone Labs, Israel), diluted 1:50 in a solution of 1:10 Ultra V Block/water. The anti-HERG antibody developed in our laboratory was diluted 1:50 as above. Further incubations were carried out for 20 min at room temperature: the first one with the prediluted biotinylated polyvalent anti-goat antibody, then with the horseradish peroxidase-conjugated streptavidin. After extensively washing with PBS, color was developed by incubating the slides with the DAB (3,3′-diamino-benzidine) chromogen solution for 5-40 min or until acceptable color intensity had been reached. Slides were then counterstained with Mayer's hematoxylin and mounted using Entellan mounting medium. Images were acquired through a Leica photocamera. Magnification was ×40.
Patch-clamp recordings
Cells plated on 35 mm Petri dishes were incubated at 37°C for appropriate times. Patch-clamp experiments were subsequently performed at room temperature with an amplifier Axopatch 2-A (Axon Instruments, Foster City, CA,USA). The whole-cell configuration of the patch-clamp technique 46 was employed using pipettes (borosilicate glass; Hilgenberg, Germany) whose resistance was in the range 2-3 MΩ. Gigaseal resistances were in the range 1-10 GΩ. Whole-cell currents were filtered at 2 KHz. For precise measurement of the gating parameters of the HERG channels, we carefully compensated pipette and cell capacitance and the series resistance before each voltage-clamp protocol run. Extracellular solutions were delivered through a nine-hole (0.6 mm), remotecontrolled linear positioner placed near the cell under study. As shown in Table 1 and Figure 1a (lanes 3 and 4) herg RNA was very rarely detected in PBMNC, while never detected in seven preparations of PBCD34 + . Cytofluorimetric analysis performed on such PBCD34
Results
Analysis of herg expression
+ confirmed that the great majority (94.3%) of these cells was in the G 0 /G 1 phase of the cell cycle (panel b in Figure 1) , with only 1.5% in S and 4.1% in the G 2 /M phase. However, when PBCD34
+ were treated for 12 h in vitro with IL3, G-CSF and GM-CSF (see Materials and methods), cells entered the mitotic cycle (see panel c in Figure  1 ) with 25.3% of cells in S. In these cells herg mRNA expression was easily detectable (see panel a in Figure 1 , lane 5). In contrast, no herg transcription was detected when cells were treated for shorter times (6 h) or on purified peripheral lymphocytes after phytohemoagglutinin stimulation (not shown). Thus, while herg is not transcribed in resting blood cells, nor in unstimulated CD34 + cells, it is up-regulated as soon as the latter are induced to enter the proliferative cycle by cytokine/growth factor stimulation. Values are the number positive/total number, with percentages in parentheses.
HERG K + channel in acute myeloid leukemia S Pillozzi et al 
Effects of HERG inhibitors on HSC and leukemic cell proliferation
The above results suggested the possible involvement of hergencoded currents in regulating proliferation of hemopoietic progenitors. To address this question, the clonogenic activity of CFU-GM present in the PBCD34 + population was then evaluated in the absence or in the presence of the antiarrhythmic drug Way 123,398, a specific blocker of HERG K + channels. As shown in Figure 2 , CFU-GM expansion in vitro in semisolid medium was drastically blocked by Way 123,398.
These results prompted us to investigate whether HERG K
+
Figure 2
Effects of HERG inhibitors on colony growth from normal peripheral blood mononuclear non-adherent cells (MNAC). 10 6 nonadherent mononuclear cells (MNAC) from normal peripheral blood were seeded as described in Materials and methods in the absence (control) or in the presence of 200 M Way 123,398. Colonies and clusters (representing CFU-GM) were counted after 14 days of incubation. Values are reported as the number of colonies and clusters (CFU-GM)/10 channels were constitutively expressed in leukemic cells, in particular in AML, possibly regulating the uncontrolled neoplastic growth of these cells. Therefore, the expression of herg and HERG channels was first studied in myeloid leukemic cell lines obtained from human AML displaying different phenotypic markers. Although at different levels, herg mRNA was detected by RT-PCR not only in FLG 29.1 cells as previously reported 29 ( Figure 3A , lane 2), but also in K562 and HL60 cell lines ( Figure 3A, lanes 3 and 4, respectively) . A typical I HERG could also be detected in both K562 and HL60 cells: an example, relative to K562 cells, is reported in Figure 3B , where the biophysical and pharmacological features of I HERG appear clearly similar to those reported in other tumor cell lines. 29 To assess whether the activity of HERG channels affects the proliferation of leukemic cell population, as reported in different experimental models (see Introduction), the effect of HERG channels inhibitors (anthiarrhythmic drugs like E4031 and Way 123,398, or CsCl 44 ) on this parameter was evaluated. As shown in Figure 4 , when FLG 29.1 leukemia cells were starved by overnight serum deprivation, their subsequent proliferation after serum re-addition was inhibited by all the above mentioned HERG inhibitors, as well as by their combination. In the latter case, no strong additive effect was observed, indicating that all the inhibitors affected the same target, namely HERG currents. Moreover the same inhibitors did not affect the proliferation of cell lines not expressing I HERG (Crociani et al, manuscript in preparation) . The impairment of cell proliferation operated by HERG inhibitors is at least in part related to a retardation of cell cycle progression, as evidenced by the increase in the percentage of cells in the G 1 phase of the cell cycle observed in FLG 29.1 cells treated with the combination of HERG inhibitors (inset to Figure 4 ) after 24 h of incubation in 1% FCS. Substantially similar results were obtained in K562 (not shown). It is worth noting that in these experiments no increase in cell death via the apoptotic pathway was observed after treatment of cells with HERG inhibitors, either in the cytofluorimetric analysis or performing the Hoechst test (not shown).
HERG K
+ channel in acute myeloid leukemia S Pillozzi et al On the whole, data presented so far suggested that HERG channels are involved in the regulation of cell cycle progression of various types of leukemia cell lines.
Expression of herg transcript and protein in primary AML cells
Experiments were then performed to study herg and HERG protein expression in primary human AML cells, as well as their role in leukemia cell proliferation. herg expression was evaluated by RT-PCR in a set of peripheral blood leukemic blasts from 46 patients with de novo AML at diagnosis. A representative example of a RT-PCR analysis is shown in Figure  5 . Table 1 shows the complete results of our analysis and gives the rates of herg expression according to the FAB type. 35 Collectively, herg appears to be expressed in 36/46 (78%) of the AML examined, with the highest incidence in the M1, M2, M3 and M4 group; FAB type M2 and M4 accounted for the majority of the patients examined.
HERG protein expression was also investigated in leukemia cell lines and some samples of AML with immunocytochemis-
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Figure 4
Effect of current inhibitors on proliferation and cell cycle progression of FLG 29. try, using the peroxidase method. In Figure 6 suggested that the expression of HERG protein can be easily detected by this method and that such expression is limited to definite cell types among the blast cell population.
To test whether HERG channel expression in primary AML could be involved in the regulation of cell proliferation, as in the above reported leukemia cell lines, a clonogenic assay was performed in some of the AML blasts examined in Table  1 , in the absence or in the presence of the specific HERG channel inhibitor Way 123,398. A strong inhibition of colony formation was observed in almost all cases examined as compared to control, when cells were seeded in semisolid medium in the presence of Way 123,398 ( Figure 7 ).
Discussion
In this paper we provide evidence that, at variance with mature PBMNC or resting PBCD34
+ cells, growth factorstimulated CD34
+ cells and AML blasts express the K + channel encoding gene herg, and that the progression along the mitotic The expression of herg was almost undetectable in PBMNC, and even in PBCD34
+ , that are in resting hemopoietic progenitors cells circulating in the bloodstream, but was capable of undergoing rapid activation of the mitotic cycle upon treatment with a cytokine/growth factor mixture. Indeed, PBCD34 + cells enter into the S phase as soon as 12 h after this treatment, and rapidly express the herg gene at that time. Many recent reports demonstrated that definite sets of genes, including those encoding growth factors and their receptors, cytokines and relative receptors, as well as transcription factors like cmyc, c-myb, c-fos and c-jun, are modulated in their transcription during response to cytokines/growth factors. 48 The results reported here demonstrate that the herg gene can be included in the set of genes activated early on during the G 0 /G 1 to S transition of hemopoietic progenitor cells. It is worth noting that recent reports demonstrated that inward rectifier K + (IRK) channels are up-regulated in cord blood CD34 + cells stimulated to enter cell cycle by a cytokine/growth factors mix. 49, 50 In particular, the IRK current was detected in resting cord blood CD34 + , and was expressed by a greater percentage of cells after 16 h incubation with IL3 and stem cell factor (SCF). We also detected the IRK current encoding gene, Kir 2.1 in PBCD34
+ before cytokine stimulation (data not shown). these data underline a profound difference between herg and Kir 2.1 genes in that only the former is turned on upon cytokine stimulation at the onset of cell cycle progression.
Results reported in this study also demonstrate that herg is expressed in myeloid leukemia cell lines and in the majority of AML cases studied. Since cells in leukemic lines are randomly distributed throughout the mitotic cycle, it is conceivable that the herg gene is constitutively expressed in these cells independently of their cell cycle status or any stimulation. By contrast, in AML cases herg is apparently expressed in a definite set of cells (see immunocytochemical experiments), consistently with the finding that only a small proportion of blasts are able to divide, most of them being terminal cells. 51 Many recent reports aimed to define the characteristics of leukemic progenitor cells present in AML have shown the constitutive activation of transcription factors like STATs 52 or NF-kB, 9 as well as aberrant expression of tumor suppressor genes IRF1 and DAPK. 8, 53 Data reported in this paper indicate the herg gene as the first K + channel enco-ding gene which is constitutively up-regulated in AML blasts, being completely turned off either in mature myeloid cells and in resting CD34 + cells. We also show that HERG channels could be proposed as regulators of immature hemopoietic cells proliferation. In fact, the specific block of I HERG in leukemia cell lines always impaired cell proliferation, irrespective of the drug's mechanism of action, 54 while not affecting growth in cell lines not expressing I HERG . The antiproliferative effect can be accounted for by an increase in the number of cells present in the G 1 phase of the cell cycle. Moreover, we show here that the clonogenic potential of either stimulated CD34
+ cells or circulating blasts of AML can be drastically reduced through specific HERG channel inhibition.
We have previously shown that HERG channels are linked to the cell cycle phases in NB cells, 28 as well as that a particular HERG protein isoform is up-regulated in the S phase of these cells (Crociani et al, manuscript in preparation) . In the present paper we provide strong evidence that HERG channel activity is necessary for the progression of leukemic cells beyond the G 1 /S boundary.
Previous reports indicated K + channels as important regulators of leukemia cell proliferation, suggesting that the activation of such channels is a prerequisite for the G 1 /S progression of cells. 10 The present paper offers a molecular dimension to this aspect, demonstrating that in activated PBCD34
+ cells, leukemia cell lines and primary AML, cell proliferation is regulated by HERG channels.
Data here reported can also explain the preferential and constitutive herg expression in tumor cells. In fact, in these cells the main role of HERG currents could be that of regulating cell cycle progression, probably by clamping the V REST values around −30/−40 mV. These are the values often directly measured in tumor cells, 25, 28, 29, 33, 34, 38 as well as in leukemic cell lines studied in this paper (see Materials and methods). The latter could be a threshold value, required for cell survival, by preventing cells from losing K + ions, a prerequisite to enter the apoptotic pathway. 55, 56 Alternatively, such values could be apt to maintain, in a properly activated state, [57] [58] [59] those voltage-dependent proteins involved in cell signalling, as well as to control the appropriate Ca 2+ entry into the cells through voltage-dependent channels. 60 On the whole, based on data reported in this study, we propose to include K + channel encoding genes, in particular the herg gene, among novel molecular markers of hematological disorders that are involved in the regulation of hemopoietic cell proliferation.
